GeminIQ Website Logo

Viewing CSTL free

Subscribe for full history, 90+ metrics, screener, watchlist...

CASTLE BIOSCIENCES INC

CSTL

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value
62641178682901209586839991
Available For Sale Securities Debt Securities Curr…
-------185174156144139
Marketable Securities Current
205198183202194185173---144-
Accounts Receivable Net Current
484243495256515046433837
Inventory Net
111010987878886
Prepaid Expense And Other Assets Current
15148121211887667
Assets Current
341329361358349349360345320296296280
Marketable Securities Noncurrent
-----6------
Accounts Receivable Net Noncurrent
222211111111
Property Plant And Equipment And Finance Lease Rig…
10510197857455514439332522
Operating Lease Right Of Use Asset
141415151611121212121212
Intangible Assets Net Including Goodwill
959710010210478106111113115117120
Other Assets Noncurrent
444111123212
Assets
561548579563545502531515487459453436
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current
1015191213977109107
Employee Related Liabilities Current
271938322518332821152922
Asset Acquisition Contingent Consideration Liabili…
21111-0-----
Operating Lease Liability Current
111121221111
Long Term Debt Current
3200210---0-
Other Accrued Liabilities Current
14119988887776
Liabilities Current
574969555137494439324836
Long Term Debt Noncurrent
78101089101010100-
Asset Acquisition Contingent Consideration Liabili…
02222-0-----
Operating Lease Liability Noncurrent
252525252514141514141413
Finance Lease Liability Noncurrent
000000000-0-
Deferred Income Tax Liabilities Net
222331240000
Other Liabilities Noncurrent
---------000
Liabilities
9186108968961757463566250
Stockholders Equity
Preferred Stock Value Outstanding
000000000000
Common Stock Value Outstanding
000000000000
Additional Paid In Capital
711700695689677666656650636623609602
Retained Earnings Accumulated Deficit
-241-239-224-222-221-226-200-210-212-221-218-216
Accumulated Other Comprehensive Income Loss Net Of…
-0-0000000-0-00-0
Stockholders Equity
470461471467455440456441424402391386
Liabilities And Stockholders Equity
561548579563545502531515487459453436
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
200200200200200200200200200200200200
Common Stock Shares Issued
313030292929282828282727
Shares Outstanding
313030292929282828282727

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-14.83%-1.82%-0.26%---------
2025-14.83%8.53%-14.29%56.72%48.24%59.99%53.71%51.58%62.52%-21.58%-21.42%-39.99%
20246.70%-6.35%-12.78%35.79%27.51%43.57%-9.99%-20.24%-21.40%-18.83%-14.91%-33.74%
2023---10.96%-1.61%-23.76%19.40%29.91%15.08%-16.89%-20.83%-0.62%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
6.04
6.75
5.26
6.47
6.85
9.37
7.29
7.78
8.12
9.25
6.20
7.70
Quick Ratio
5.58
6.23
4.99
6.09
6.45
8.89
6.97
7.45
7.75
8.82
5.90
7.34
Working Capital
284.59M
280.14M
292.42M
302.26M
297.78M
312.11M
310.76M
300.48M
280.95M
263.82M
247.97M
243.30M
Leverage & Debt
Debt to Equity
0.19
0.19
0.23
0.20
0.20
0.14
0.17
0.17
0.15
0.14
0.16
0.13
Interest Coverage TTM
-85.62
-163.99
-497.79
-226.84
-69.64
-23.77
15.03
-2.13
-54.71
-1,996.48
-6,179.73
-6,550.08
Debt Ratio
0.16
0.16
0.19
0.17
0.16
0.12
0.14
0.14
0.13
0.12
0.14
0.12
Efficiency & Turnover
Asset Turnover TTM
0.65
0.65
0.62
0.64
0.67
0.72
0.67
0.66
0.63
0.57
0.49
0.43
Days Sales Outstanding TTM
51.41
52.95
50.15
52.99
51.81
52.08
49.20
51.06
49.05
51.26
51.30
56.88
Receivables Turnover TTM
7.10
6.89
7.28
6.89
7.05
7.01
7.42
7.15
7.44
7.12
7.12
6.42
Per Share Metrics
Diluted EPS TTM
-0.64
-0.43
-0.83
-0.42
-0.32
-0.18
0.62
0.21
-0.11
-1.12
-2.14
-2.81
Free Cash Flow Per Share TTM
-0.02
0.15
0.98
0.87
1.19
1.46
1.32
1.24
0.73
-0.23
-0.72
-1.56
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
77.26%
77.88%
79.37%
79.94%
81.00%
81.94%
81.87%
81.90%
81.86%
80.58%
79.53%
78.08%
Operating Profit Margin TTM
-8.99%
-9.79%
-12.44%
-10.17%
-6.66%
-3.97%
2.61%
-0.33%
-5.48%
-16.72%
-30.93%
-44.35%
Net Profit Margin TTM
-5.43%
-3.78%
-7.02%
-3.56%
-2.73%
-1.46%
5.49%
1.95%
-1.08%
-12.28%
-26.15%
-39.32%
Growth Metrics
Net Revenue Growth (1Y)
3.18%
-2.06%
3.66%
10.15%
20.40%
38.43%
51.09%
62.43%
71.67%
64.71%
60.38%
55.17%
Net Income Growth (1Y)
105.10%
153.15%
-232.41%
-301.42%
205.45%
-83.54%
-131.75%
-108.05%
-96.51%
-57.06%
-14.41%
42.59%
EPS Growth (1Y)
95.08%
142.31%
-226.88%
-292.87%
192.06%
-84.19%
-130.64%
-107.76%
-96.63%
-58.43%
-16.79%
39.84%
Valuation Metrics
P/E TTM
-37.34
-57.18
-46.67
-54.10
-62.37
-112.99
40.57
130.70
-194.21
-19.77
-10.06
-6.00
P/B TTM
1.54
1.59
2.39
1.42
1.30
1.30
1.62
1.80
1.42
1.51
1.48
1.17
P/S TTM
2.03
2.16
3.28
1.93
1.71
1.65
2.23
2.55
2.09
2.43
2.63
2.36
Market Cap
725.02M
733.77M
1.13B
661.99M
590.42M
572.75M
740.23M
794.00M
601.85M
608.79M
578.39M
453.23M
Enterprise Value
672.98M
680.08M
1.02B
586.49M
518.23M
493.10M
630.54M
709.05M
526.29M
535.84M
479.57M
362.00M
Calculated Values
Free Cash Flow TTM
-489.00K
4.52M
28.33M
25.38M
34.54M
41.75M
36.54M
34.54M
20.13M
-6.46M
-19.25M
-41.83M
Net Debt
-52.04M
-53.70M
-106.67M
-75.51M
-72.19M
-79.66M
-109.69M
-84.94M
-75.56M
-72.95M
-98.82M
-91.22M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-16Sale
Owner: Oelschlager, Kristen M
Title: Chief Operating Officer
Shares: 8,587
Price/Share: $20.71
Value: $177,836.77
Shares Owned: 30,460
Relationship: Officer
Ownership: Direct
2026-06-15Sale
Owner: Maetzold, Derek J
Title: Pres. & Chief Exec. Officer
Shares: 550
Price/Share: $20.66
Value: $11,363.00
Shares Owned: 21,479
Relationship: Director,Officer
Ownership: Direct
2026-06-01Sale
Owner: Maetzold, Derek J
Title: Pres. & Chief Exec. Officer
Shares: 6,214
Price/Share: $20.86
Value: $129,624.04
Shares Owned: 21,479
Relationship: Director,Officer
Ownership: Direct
2026-05-21Sale
Owner: Maetzold, Derek J
Title: Pres. & Chief Exec. Officer
Shares: 420
Price/Share: $20.20
Value: $8,484.00
Shares Owned: 21,479
Relationship: Director,Officer
Ownership: Direct
2026-05-07Sale
Owner: Maetzold, Derek J
Title: Pres. & Chief Exec. Officer
Shares: 6,214
Price/Share: $22.34
Value: $138,820.76
Shares Owned: 21,479
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
88.25%
Inst. Shares: 26,375,659
Shares Outstanding: 29,889,000
2025-12-31
91.64%
Inst. Shares: 26,563,174
Shares Outstanding: 28,986,000
2025-09-30
88.72%
Inst. Shares: 25,794,148
Shares Outstanding: 29,073,000
2025-06-30
87.53%
Inst. Shares: 25,309,035
Shares Outstanding: 28,914,000
2025-03-31
84.35%
Inst. Shares: 24,131,115
Shares Outstanding: 28,609,000

CASTLE BIOSCIENCES INC (CSTL) — SEC Financial Statements & Analysis

CASTLE BIOSCIENCES INC (CSTL) is a services-medical laboratories company, incorporated in DE. CASTLE BIOSCIENCES INC trades on Nasdaq as: CSTL. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), CASTLE BIOSCIENCES INC reported a 3.18% year-over-year revenue growth, a Gross Profit Margin of 77.26% (TTM), a Debt-to-Equity ratio of 0.19x, a Price-to-Sales (P/S) ratio of 2.03x (TTM), a Price-to-Book (P/B) ratio of 1.54x (TTM), at a market cap of $725.02M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
3.18%
Gross Profit Margin TTM
77.26%
Debt To Equity
0.19x
P/S TTM
2.03x
P/B TTM
1.54x
Market Cap
$725.02M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is CASTLE BIOSCIENCES INC in?

CASTLE BIOSCIENCES INC (CSTL) operates in the Services-Medical Laboratories industry.

What is CSTL's market cap?

CASTLE BIOSCIENCES INC (CSTL) has a market capitalization of $725.02M as of 2026-06-30.

What exchange does CSTL trade on?

CASTLE BIOSCIENCES INC (CSTL) trades on the Nasdaq.

Where is CASTLE BIOSCIENCES INC incorporated?

CASTLE BIOSCIENCES INC is incorporated in DE.

Wall Street's data.
Main Street's price.